ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer-Reference-Cited by-同舟云学术

ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer

Published:2018-02 Issue: Volume:116 Page:15-24
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

McLeer-Florin Anne,Duruisseaux Michael,Pinsolle Julian,Dubourd Sylvian,Mondet Julie,Phillips Houlbracq Mathilde,Magnat Nelly,Fauré Julien,Chatagnon Amandine,de Fraipont Florence,Giaj Levra Matteo,Toffart Anne-Claire,Ferretti Gilbert,Hainaut Pierre,Brambilla Elisabeth,Moro-Sibilot Denis,Lantuejoul Sylvie

Funder

French Institut National du Cancer (INCa)

Grenoble-Alpes University Hospital (DRCI REALK project)

Grenoble Lions Club

Groupement des Entreprises Françaises de Lutte Contre Cancer (GEFLUC) Grenoble Dauphiné-Savoie

Intergroupe Francophone de Cancérologie Thoracique (IFCT) Alain Depierre Grant

ARISTOT (Association de Recherche, d’Information Scientifique et Thérapeutique en Oncologie Thoracique)

Pfizer

Novartis

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference52 articles.

1. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT);Barlesi;Lancet,2016

2. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

3. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer;Shaw;N. Engl. J. Med.,2013

4. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N. Engl. J. Med.,2014

5. First-Line Ceritinib Versus Chemotherapy in Patients With ALK-Rearranged (ALK+) NSCLC: A Randomized, Phase 3 Study (ASCEND-4);De Castro,2016

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shifting from Immunohistochemistry to Screen for ALK Rearrangements: Real-World Experience in a Large Single-Center Cohort of Patients with Non-Small-Cell Lung Cancer;Cancers;2024-06-14

2. Overcoming Central β-Sheet #6 (Cβ6) ALK Mutation (L1256F), TP53 Mutations and Short Forms of EML4-ALK v3/b and v5a/b Splice Variants are the Unmet Need That a Re-Imagined 5th-Generation (5G) ALK TKI Must Deliver;Lung Cancer: Targets and Therapy;2024-02

3. Detection of clinically actionable gene fusions by next‐generation sequencing‐based RNA sequencing of non–small cell lung cancer cytology specimens: A single‐center experience with comparison to fluorescence in situ hybridization;Cancer Cytopathology;2023-09-25

4. A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma;Translational Lung Cancer Research;2023-07

5. Patient-led advocacy in ALK-positive lung cancer;Translational Lung Cancer Research;2023-06